What are the recommended parameters for blood pressure (BP) management, including treatment thresholds, target values, first‑line pharmacologic options, and lifestyle interventions?

Blood Pressure Management Parameters

For most adults with hypertension, initiate pharmacological treatment at BP ≥140/90 mmHg and target BP <130/80 mmHg, using first-line therapy with ACE inhibitors/ARBs, calcium channel blockers, or thiazide diuretics, while simultaneously implementing lifestyle modifications including sodium restriction, weight loss, and increased physical activity. 1

Diagnostic Thresholds

• Office BP ≥140/90 mmHg confirms hypertension, particularly when corroborated by home BP ≥135/85 mmHg or 24-hour ambulatory BP ≥130/80 mmHg 1
• Use validated automated upper arm cuff devices with appropriate cuff size, measuring BP in both arms at first visit and using the arm with higher readings 1
• Confirm diagnosis with repeated measurements over 2-3 office visits before initiating treatment 1

Treatment Initiation Thresholds

Grade 1 Hypertension (140-159/90-99 mmHg)

• Start drug treatment immediately in high-risk patients: those with CVD, CKD, diabetes, organ damage, or aged 50-80 years 1
• For low-moderate risk patients: initiate lifestyle interventions first, then add pharmacological treatment if BP remains elevated after 3-6 months 1

Grade 2 Hypertension (≥160/100 mmHg)

• Start drug treatment immediately for all patients, regardless of cardiovascular risk 1
• Initiate lifestyle interventions concurrently 1

Blood Pressure Targets

General Adult Population

• Target BP <130/80 mmHg for most adults if tolerated 1
• Minimum reduction goal: 20/10 mmHg from baseline 1
• Achieve target within 3 months of treatment initiation 1

Special Populations

Diabetes:

• Initiate treatment at BP ≥140/90 mmHg 1
• After maximum 3 months of lifestyle intervention, start pharmacological treatment at confirmed BP ≥130/80 mmHg 1
• Target systolic BP to 130 mmHg and <130 mmHg if tolerated, but not <120 mmHg 1
• For patients ≥65 years with diabetes: target systolic BP range of 130-139 mmHg 1

Chronic Kidney Disease:

• Treat at BP ≥140/90 mmHg with lifestyle advice and medication 1
• Target systolic BP to 130-139 mmHg for most CKD patients 1
• For moderate-to-severe CKD with eGFR >30 mL/min/1.73 m²: target systolic BP to 120-129 mmHg if tolerated 1
• Use RAS blockers (ACE inhibitors or ARBs) as part of treatment strategy when microalbuminuria or proteinuria present 1

Pregnancy:

• Initiate treatment at systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg for gestational hypertension, pre-existing hypertension with gestational component, or hypertension with organ damage/symptoms 1
• For other pregnant patients: initiate at systolic BP ≥150 mmHg or diastolic BP ≥95 mmHg 1
• Target BP <140/90 mmHg but not <80 mmHg diastolic 1
• Systolic BP ≥170 mmHg or diastolic BP ≥110 mmHg requires immediate hospitalization 1

Elderly and Frail:

• Consider monotherapy in patients >80 years or frail 1
• Individualize targets based on frailty and tolerability 1

First-Line Pharmacological Options

Non-Black Patients

1. Start with low-dose ACE inhibitor or ARB 1
2. Add DHP calcium channel blocker 1
3. Increase to full doses 1
4. Add thiazide or thiazide-like diuretic 1
5. Add spironolactone or alternatives (amiloride, doxazosin, eplerenone, clonidine, or beta-blocker) if needed 1

Black Patients

1. Start with low-dose ARB plus DHP calcium channel blocker or DHP-CCB plus thiazide/thiazide-like diuretic 1
2. Increase to full doses 1
3. Add diuretic or ACE inhibitor/ARB 1
4. Add spironolactone or alternatives if needed 1

Heart Failure Considerations

• HFrEF/HFmrEF: Use ACE inhibitor (or ARB if not tolerated) or ARNI, beta-blocker, MRA, and SGLT2 inhibitors 1
• HFpEF: SGLT2 inhibitors recommended; ARBs and/or MRAs may be considered for BP above target 1

Lifestyle Interventions

All patients should implement the following modifications concurrently with pharmacological therapy 1, 2:

• Dietary sodium reduction and potassium supplementation 2
• Weight loss for overweight/obese patients 2
• Healthy dietary pattern (low sodium, high potassium) 1, 2
• Regular physical activity 2
• Alcohol moderation or elimination 2

The BP-lowering effects of individual lifestyle components are partially additive and enhance pharmacological therapy efficacy 2.

Key Implementation Strategies

• Simplify regimens with once-daily dosing and single-pill combinations 1
• Monitor adherence regularly 1
• Consider dual-drug therapy initiation at BP ≥160/100 mmHg in higher-resource settings 3
• Refer to hypertension specialist if BP remains uncontrolled despite appropriate therapy 1

Common Pitfalls

• Avoid therapeutic inertia—escalate therapy promptly if targets not achieved within 3 months 1, 4
• Do not lower diastolic BP below 80 mmHg in pregnant patients 1
• Do not target systolic BP <120 mmHg in diabetic patients 1
• Ensure proper BP measurement technique with validated devices and appropriate cuff size 1